Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease

References

• Borley NR, Mortensen NJ, Jewell DP. Preventing postoperative recurrence of Crohn's disease. Br J Surg 1997; 84: 1493–502
   PubMed Web of Science ®Google Scholar
• Lochs H, Mayer M, Fleig WE, Mortensen PB, Bauer P, Genser D, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI [comments]. Gastroenterology 2000; 118: 264–73
   PubMed Web of Science ®Google Scholar
• McLeod RS, Wolff BG, Steinhart AH, Carryer PW, O'Rourke K, Andrews DF, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995; 109: 404–13
   PubMed Web of Science ®Google Scholar
• Brignola C, Cottone M, Pera A, Ardizzone S, Scribano ML, De Franchis R, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 1995; 108: 345–9
   PubMed Web of Science ®Google Scholar
• Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249–66
   PubMed Web of Science ®Google Scholar
• Hellers G, Cortot A, Jewell D, Leijonmarck CE, Lofberg R, Malchow H, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999; 116: 294–300
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninckx F, Aerts R, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617–21
   PubMed Web of Science ®Google Scholar
• Pearson DC, May GR, Fick G, Sutherland LR. Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev 2000; 2
   Google Scholar
• Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123: 132–42
   PubMed Web of Science ®Google Scholar
• Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004; 127: 723–9
   PubMed Web of Science ®Google Scholar
• Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004; 127: 730–40
   PubMed Web of Science ®Google Scholar
• Nos P, Hinojosa J, Aguilera V, Moles JR, Pastor M, Ponce J, et al. Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease. Gastroenterol Hepatol 2000; 23: 374–8
   PubMedGoogle Scholar
• Best WR, Becktel JM. The Crohn's disease activity index as a clinical instrument. Recent advances in Crohn's disease, A Pena, IT Weterman, CC Booth, W Strober. Martinus Nijhoff, The Hague 1981; 7–12
   Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; Suppl 170: 2–6
   Web of Science ®Google Scholar
• Morson BS. Histopathology of Crohn's disease. Proc R Soc Med 1968; 61: 79–81
   PubMedGoogle Scholar
• Andersson P, Olaison G, Bodemar G, Almer S, Arvidsson M, Dabrosin-Soderholm J, et al. Low symptomatic load in Crohn's disease with surgery and medicine as complementary treatments. Scand J Gastroenterol 1998; 33: 423–9
   PubMedGoogle Scholar
• Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci 1985; 30: 58–64
   PubMed Web of Science ®Google Scholar
• Korelitz BI, Adler DJ, Mendelsohn RA, Sacknoff AL. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol 1993; 88: 1198–205
   PubMed Web of Science ®Google Scholar
• Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 1992; 33: 331–5
   PubMed Web of Science ®Google Scholar
• Tytgat GN, Mulder CJ, Brummelkamp WH. Endoscopic lesions in Crohn's disease early after ileocecal resection. Endoscopy 1988; 20: 260–2
   PubMedGoogle Scholar
• Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 665–72
   PubMed Web of Science ®Google Scholar
• D'Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease [comments]. Gastroenterology 1997; 112: 1475–81
   PubMed Web of Science ®Google Scholar
• Smedh K, Olaison G, Franzen L, Sjodahl R. Endoscopic and external bowel changes and histopathology in patients with Crohn's disease. Br J Surg 1995; 82: 191–4
   PubMedGoogle Scholar